← Back to Search
Salmon Calcitonin-loaded Eudragit® And Eudragit®-PLGA Nanoparticles: In Vitro And In Vivo Evaluation
M. Cetin, M. S. Aktaş, I. Vural, M. Ozturk
Published 2012 · Materials Science, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
The main objective of this study was to prepare salmon calcitonin (sCT)-loaded Eudragit®RSPO, Eudragit®L100 and Eudragit®-poly(lactic-co-glycolic acid) blend nanoparticles for in vitro and in vivo evaluation as an oral drug delivery system. The prepared nanoparticles ranged in size from 179.7 to 308.9 nm with a polydispersity index between 0.051 and 2.75, and had surface charges ˜ −11 to +6 mV. Efficient sCT encapsulation and release was observed with all the nanoparticle formulations. The polymer type was an important factor that influenced the release characteristics and the in vivo hypocalcemic effect. Nanoparticle formulations were also prepared with sodium taurodeoxycholate (NaTDC) and characterized. No statistically significant difference was noted between the hypocalcemic effect of any of the nanoparticle formulations with and without NaTDC (p > 0.05). The use of Eudragit®RSPO nanoparticles appears to be a potential approach for the oral delivery of sCT.
This paper references
Chitosan nanoparticles for oral drug and gene delivery
Katherine Bowman (2006)
The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles.
Robert M. Samstein (2008)
Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts.
Keon-Hyoung Song (2005)
Increased paracellular absorption by bile salts and P-glycoprotein stimulated efflux of otilonium bromide in Caco-2 cells monolayers as a model of intestinal barrier.
Rose-Marie Catalioto (2008)
Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers
B. Mukherjee (2008)
A study of drug release from homogeneous PLGA microstructures.
G. Acharya (2010)
Retention and transit of intestinal mucoadhesive films in rat small intestine.
S. Eaimtrakarn (2001)
Enteral insulin delivery by microspheres in 3 different formulations using Eudragit L100 and S100
I. Morishita (1993)
Q 2 b : Validation of analytical procedures : Methodology
N Jawahar (1997)
Effect of surfactants on the nasal absorption of insulin in rats
Hirai Shinichiro (1981)
Peroral route: an opportunity for protein and peptide drug delivery.
A. Sood (2001)
In vitro evaluation of polymeric excipients protecting calcitonin against degradation by intestinal serine proteases.
D. Guggi (2003)
The oral delivery of therapeutic proteins [Online
B. Sarmento (2008)
Oral Delivery of Mono-PEGylated sCT (Lys18) in Rats: Regional Difference in Stability and Hypocalcemic Effect
S. Mansoor (2005)
Enhanced oral absorption of salmon calcitonin-encapsulated PLGA nanoparticles by adding organic substances
T. Jung (2009)
Preparation and In Vitro/In Vivo Evaluation of Gliclazide Loaded Eudragit Nanoparticles as a Sustained Release Carriers
P. Devarajan (2007)
Size effect of PLGA spheres on drug loading efficiency and release profiles
G. Dawes (2009)
Utility of pharmacodynamic measures for assessing the oral bioavailability of peptides. 1. Administration of recombinant salmon calcitonin in rats.
P. Sinko (1995)
Protein and Peptide Drug Delivery: Oral Approaches
J. Shaji (2008)
Degradation pathways, analytical characterization and formulation strategies of a peptide and a protein. Calcitonine and human growth hormone in comparison.
M. Cholewinski (1996)
Preparation and characterization of drug-loaded polymethacrylate microspheres by an emulsion solvent evaporation method
B. Kim (2002)
A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Abdallah Makhlof (2011)
Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles.
U. Bilati (2005)
Formulation and In vitro Characterization of Eudragit® L100 and Eudragit® L100-PLGA Nanoparticles Containing Diclofenac Sodium
M. Çetin (2010)
Formulation and Evaluation of Chitosan-Based Ampicillin Trihydrate Nanoparticles
P. Saha (2010)
PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-α carriers
Y. Li (2001)
A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery.
M. Garcia-Fuentes (2005)
Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems.
C. Reis (2006)
Effect of pH, dietary proteins and trypsin inhibitors on the hydrolytic rate of human granulocyte colony-stimulating factor (G-CSF) by rat digestive enzymes.
K. Takada (1991)
Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation
S. Saremi (2011)
Preparation and in vitro–in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles
Eliza Główka (2010)
Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?
T. Jung (2000)
In Vivo Evaluation of an Oral Salmon Calcitonin-Delivery System Based on a Thiolated Chitosan Carrier Matrix
D. Guggi (2004)
Preparation and Characterization of Salmon Calcitonin–biotin Conjugates
M. Çetin (2008)
Gastroresistant microparticles containing sodium alendronate prevent the bone loss in ovariectomized rats.
L. Cruz (2010)
Mucoadhesive liposomal delivery systems: the choice of coating material
P. R. Karn (2011)
Oral peptide delivery using nanoparticles composed of novel graft copolymers having hydrophobic backbone and hydrophilic branches
Shinji Sakuma (1997)
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.
A. des Rieux (2006)
Advances in oral transmucosal drug delivery.
V. F. Patel (2011)
Regional permeability of salmon calcitonin in isolated rat gastrointestinal tracts: Transport mechanism using Caco-2 cell monolayer
R. Shah (2008)
The use of Eudragit RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione.
A. Lopedota (2009)
Poly(vinyl alcohol) nanoparticles prepared by freezing-thawing process for protein/peptide drug delivery.
J. K. Li (1998)
Chitosan versus thiolated chitosans as polymers in mucoadhesive drug delivery – a comparative study
M Varaprasad Reddy (2010)
Contribution of ion pair complexation with bile salts to biliary excretion of organic cations in rats.
I. Song (2001)
Oral Delivery of Therapeutic Proteins
Yun Bai (2005)
Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency.
Xiangrong Song (2008)
Nanoparticles - A Review
V. Mohanraj (2007)
Gastrointestinal mucoadhesive patch system (GI-MAPS) for oral administration of G-CSF, a model protein.
S. Eiamtrakarn (2002)
Handbook of Pharmaceutical Excipients
Pharmaceutical Press (2012)
Formulation and in vitro, in vivo evaluation of extended- release matrix tablet of Zidovudine: Influence of combination of hydrophilic and hydrophobic matrix formers
Atul Kuksal (2008)
Mucoadhesive Sustained Drug Delivery System Based on Cationic Polymer and Anionic Cyclodextrin/Triclosan Complex
H. Sigurdsson (2002)
Handbook of Pharmaceutical Excipients
R. C. Rowe (1994)
Preparation and Characterisation of PLGA-Nanoparticles containing an Anti-hypertensive agent
N. Jawahar (2009)
Regional oral absorption, hepatic first-pass effect, and non-linear disposition of salmon calcitonin in beagle dogs.
Y. Hee Lee (2000)
Nanoparticles containing ketoprofen and acrylic polymers prepared by an aerosol flow reactor method
Hannele Eerikäinen (2008)
Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
M. P. Ettinger (2003)
Preparation and In Vitro Evaluation of bFGF-Loaded Chitosan Nanoparticles
M. Cetin (2007)
This paper is referenced by
Nanotized Curcumin and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis
B. Tiwari (2016)
Functionalized Polymers for Enhance Oral Bioavailability of Sensitive Molecules
Y. A. Pérez (2016)
Mucoadhesive intestinal devices for oral delivery of salmon calcitonin.
V. Gupta (2013)
Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs.
T. Fan (2014)
Emerging Technologies of Polymers for Nanomedicine Applications
T. Andreani (2016)
Animal models for evaluation of oral delivery of biopharmaceuticals
Stine Harloff-Helleberg (2017)
Absorption-Enhancing Effects of Bile Salts
E. Moghimipour (2015)
Nanocarriers protecting toward an intestinal pre-uptake metabolism.
Wongsakorn Suchaoin (2017)
Functionalized materials for multistage platforms in the oral delivery of biopharmaceuticals
Francisca Araújo (2017)
Formulation, characterization and permeability study of nano particles of lipo-endomorphin-1 for oral delivery
S. Eskandari (2013)
Formulation and in vitro characterization of poly(dl-lactide-co-glycolide)/Eudragit RLPO or RS30D nanoparticles as an oral carrier of levofloxacin hemihydrate
Azza A. Hasan (2016)
Development of a polysaccharide based multi-unit nanofiber mat for colon-targeted sustained release of salmon calcitonin.
Kun Feng (2019)
Nanoparticles as 'smart' pharmaceutical delivery.
C. Chakraborty (2013)
Enhancement of oral bioavailability of salmon calcitonin through chitosan‐modified, dual drug‐loaded nanoparticles
L. Liu (2019)
Functional PLGA NPs for oral drug delivery: recent strategies and developments.
L. Martín-Banderas (2013)
Fabrication of core–shell PLGA/PLA–pNIPAM nanocomposites for improved entrapment and release kinetics of antihypertensive drugs
T. Basu (2018)
Polymeric nanoparticle drug delivery technologies for oral delivery applications
Eric M. Pridgen (2015)
Potentials of human bile acids and their salts in pharmaceutical nano delivery and formulations adjuvants.
S. Kecman (2019)
Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles.
A. Umerska (2014)
Self-assembled hyaluronate/protamine polyelectrolyte nanoplexes: synthesis, stability, biocompatibility and potential use as peptide carriers.
A. Umerska (2014)